Crutcher, W.A. , Moschella, S.L.: Double-blind controlled crossover high dose study of Azaribine in psoriasis. Br. J. Dermatol., 22: 199, 1975.
4.
Keefer, R.A. , Roenigk, H.H., Jr., Hawk, W.A.: Azanbine therapy for psoriasis. Evaluation of potential effects on the liver and other organ systems. Arch. Dermatol., 111; 853, 1975.
5.
Brustein, D.M. , Scher, R.K., Auerbach, R.: Hyperlipoproteinaemia and psoriasis. Lancet, 1: 154, 1976.
6.
Menon, I.S., Cunliffe, W.J., Dewar, H.A.: Preliminary report of beneficial effect of phenformin in combination with ethyloestreyol in treatment of cutaneous vasculitis and Behcet's syndrome . Postgrad. Med. J., 45: 62, 1969.
7.
Sun, N.C.J., Conn, D.L., Schroeter, A.L., et al.: Skin fibrinolytic activity in cutaneous and systemic vasculitis . Mayo Clin. Proc., 51: 216, 1976.
8.
Fearnley, G.R. , Balmforth, G.V., Fearnley, E.: Evidence of a diurnal fibrinolytic rhythm with a simple method of measuring natural fibrinolysis. Clin. Sci., 16: 645, 1957.
9.
Browse, N.L., Gray, L., Jarret, P.E., et al.: Blood and vein-wall fibrinolytic activity in health and vascular disease. Br. Med. J., 1: 478, 1977.
Kounis, N.G.: Contribution to the Treatment and Prevention of Thromboembolic Disease with Arvin, Heparin, Phenformin, Ethyloestrenol and Warfarin. M.D. Thesis (in Greek). Athens University, Athens, Greece, 1976.
16.
Rosenberg, S.A., Diamond. H.D.Taslowitz, B., et al.: Lymphosarcoma: A review of 1263 cases . Medicine (Baltimore), 40: 31, 1961.
17.
Griffiths, N.J., Woodford, M., Irving, M.H.: Alteration in fibrinolytic capacity after operation. Lancet, 2: 635, 1977.
18.
Clifton, E. , Clarke, R., Murphy, J.: Studies on fibrinolytic activity with venous occlusion: Treatment of thrombophlebitis. Surgery, 50: 644, 1961.
19.
Rawles, J.M. , Warlow, C., Ogston, D.: Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br. Med. J., 2: 61, 1975.
20.
McKay, D.G. : Tissue damage in disseminated intravascular coagulation: Mechanisms of localization of thrombi in the micro-circulation . Thromb. Diath. Haemorrh. Suppl.36: 67, 1969.
21.
Sun, N.C.J. , Bowie, E.J.W., Titus, J.L., et al.: Effect of induced chronic intravascular coagulation on plasminogen activator in dogs. Thromb. Diath. Haemorrh., 32: 189, 1974.
22.
Trousseau, A.: Lectures on clinical medicine delivered at Hotel Dieu, Paris. The New Sydenham Society, 5: 287, 1872.
23.
Moolten, S.E. , Jenning, P.B., Solden, A.: Dietary fat and platelet adhesiveness in atherosclerosis and diabetes. Am. J. Cardio., 11: 290, 1963.
Amudsen, M.A. , Spittall, J.A., Jr., Thompson , J.H., Jr., et al.: Hypercoagulability associated with malignant disease and with postoperative state. Evidence for elevated levels of antihaemophilic globulin. Ann. Intern. Med., 58: 608, 1963.
26.
Miller, S.P. , Sanchez-Avalos, J., Stefanski, T., et al.: Coagulation disorders in cancer. 1. Clinical and laboratory studies. Cancer, 20: 1452, 1967.
27.
Kwaan, H.L. , McFadzean, A.J.S.: The inhibition of clot lysis by coricotrophin . Lancet, 1: 136, 1956.
28.
Thomas, L., Good, R.A.: The effect of cortisone on the Shwartzman reaction: The production of lesions resembling the dermal and generalized Shwartzman reaction by a single injection of bacterial toxin in cortisone-treated rabbits. J. Exp. Med. , 25: 409, 1952.
29.
Kwaan, H.L. , McFadzean, A.J.C., Cook, J.: Plasma fibrinolytic activity in cirrhosis of the liver. Lancet, 1: 132, 1956.
30.
Chakrabarti, R., Fearnley, G.R., Hocking, E.D.: Effect of corticosteroid therapy on fibrinolysis in patients with inflammatory and noninflammatory conditions. Br. Med. J., 1: 534, 1964.